The Group Room at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium

The 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium was a huge success!

We produced more than 20 interviews on topics ranging from the BOLERO-2 and CLEOPATRA trials (Jose Baselga) to medical economics (Eric Winer), breast cancer and the environment (Robert Hiatt), the treatment of young women with breast cancer (Ann Partridge), metastatic breast cancer treatment update (Hope Rugo) and so much more.

For a complete list of all the interviews conducted, check out our full video listing below.

 

Topics and guests include:

C. Kent Osborne, MD: Breast Cancer Treatment – A Year In Review  
Dr. C. Kent Osborne (Baylor College of Medicine), the co-director of the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), discusses breast cancer advances and treatment highlights over the past year.

Jose Baselga, MD, PhD: BOLERO-2 Findings Confirm Efficacy of Everolimus Plus Exemestane  
Dr. Jose Baselga (Massachusetts General Hospital) discusses the exciting data for the HER2-negative breast cancer patient — the BOLERO-2 trial released at the CTRC-AACR 34th Annual San Antonio Breast Cancer Symposium.

Jose Baselga, MD, PhD: CLEOPATRA Pertuzumab Trial Increases Progression-Free Survival   
Dr. Jose Baselga (Massachusetts General Hospital) discusses the exciting data for the HER2-positive breast cancer patient — the CLEOPATRA trial.

Leslie Botnick, MD: Radiation Oncology Data from SABCS 2011 and Breast Cancer and the Importance of Radiation Oncology and What Breast Cancer Patients Need to Know About Radiation Oncology
Dr. Leslie Botnick (Vantage Oncology) discusses Brachytherapy, the evolution of radiation oncology in breast cancer treatment and what every breast cancer patient needs to know about radiation oncology before starting treatment.

Stefan Gluck, MD: Latina’s With Breast Cancer Face Higher Mortality Rates and Avastin Improves PFS in HER2-Positive Breast Cancer in AVEREL Study
Dr. Stefan Gluck (Sylvester Comprehensive Cancer Center, University of Miami Health Systems) discusses the data coming out of SABCS on Latina’s and breast cancer and the most recent Avastin data.

Julie R. Gralow, MD: SWOG SO226 Trial and Bisphosphonates Update  
Dr. Julie R. Gralow (Fred Hutchinson Cancer Research Center), discusses the SWOG SO226 and gives an update on bisphosphonates and osteonecrosis of the jaw.

Robert A. Hiatt, MD, PhD: Institute of Medicine Report (IOM) – Breast Cancer & the Environment  
Dr. Robert A. Hiatt (Helen Diller Family Comprehensive Cancer Center / University of California San Francisco) discusses the Institute of Medicine Report on Breast Cancer and the Environment: A Life-Course Approach.

Clifford A. Hudis, MD: What’s New With Chemotherapy Trials?  and The Value of Progression-Free Survival (PFS)  and Brain Metastasis and Breast Cancer
Dr. Clifford Hudis (Memorial Sloan Kettering Cancer Center) discusses what’s new with chemotherapy trials, the value of progression-free survival and brain metastasis in breast cancer.

Joanne Mortimer, MD: Breast to Brain Metastases and Impact of Treatment on Bone & Breast Cancer Recurrences
Dr. Joanne Mortimer (City of Hope Comprehensive Medical Center) discusses an ongoing study at City of Hope involving breast to brain metastases as well as the impact of treatment on bones and the incidence breast cancer recurrence.

Ann Partridge, MD, MPH: Treatment of Young Women With Breast Cancer and How Important Are Breast Self-Exams?  
Dr. Ann Partridge (Dana-Farber Cancer Institute) discusses the treatment of young women with breast cancer and exactly how important are breast self-exams?

Martine Piccart, MD, PhD: Her Goals As the Current President Of ESMO and What Is Needed From Patients To Help Facilitate the Research Process and IMPAKT Meeting 2012
Prof./Dr. Martine Piccart (Institut Jules Bordet) discusses her goals during her ESMO presidency, what patients need to know about the research process and how they can help as well as a preview of the upcoming IMPAKT Meeting, May 3-5 in Brussels, Belgium.

Hope Rugo, MD: Advances and Challenges In the Treatment of Metastatic Breast Cancer and Chemotherapy Agents and Breast Cancer Treatment  
Dr. Hope Rugo (Helen Diller Family Comprehensive Cancer Center / University of California San Francisco), discusses the advances and challenges in the treatment of metastatic breast cancer and the future of chemotherapy agents in breast cancer treatment.

Sasha Vukelja, MD: Seeds From My Patients
Dr. Sasha Vukelja (Texas Oncology, Tyler, TX) discusses her new book, Seeds From My Patients. All proceeds from the book go to benefit the FitSTEPS for Life Program sponsored by the Cancer Foundation for Life in Tyler, Texas.

Eric P. Winer, MD: Endocrine Therapy For Breast Cancer – Looking Into the Future
Dr. Eric Winer (Dana-Farber Cancer Institute) presented one of the plenary sessions SABCS.  His talk was on endocrine therapy and looking into the future.

Eric P. Winer, MD: Medical Economics – The Cost of Care
Dr. Eric Winer (Dana-Farber Cancer Institute) moderated a panel at SABCS focusing on medical economics and the cost of cancer care.  How do we begin to address these issues?

The Group Room at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium was made possible by support from:

Comments

Leave a Reply